NEWS: Navi Secures $2.3 Million CRC-P Grant Funding

Navi Medical Technologies Secures $2.3 Million CRC-P Grant Funding to further development of Neonav® ECG Tip Location System

Design + Industry (D+I), is pleased to announce our collaboration with Navi Medical Technologies on securing a $2.3 million Cooperative Research Centres Projects (CRC-P) grant. The grant will further the development of the Neonav® ECG Tip Location System (currently in development), a medical device aimed at accurately and non-invasively locating catheter tips in critically-ill newborns and children.

The Neonav® ECG Tip Location System addresses the need for improved accuracy and real-time feedback during and after catheter insertion procedures. Currently, the lack of such feedback results in high rates of misplacement and migration of central lines, posing risks and complications for young patients. By leveraging Navi's proprietary algorithm, the Neonav system will offer fast and precise location detection of central lines, allowing clinicians to deliver therapies more efficiently and safely.

The CRC-P grant will play a crucial role in supporting Navi Medical Technologies, in collaboration with the University of Melbourne, the Royal Women's Hospital, and Design + Industry, in an upcoming pivotal clinical trial. The trial will generate essential data for FDA clearance and represents a significant step forward in bringing the Neonav device to market.

"We are thrilled to be collaborating with Navi Medical Technologies on this project," said Rod Wiebenga, Head of D+I Melbourne. "The CRC-P grant funding represents an endorsement of Navi's potential to enhance the standard of care for critically-ill newborns and children. Our shared vision of improving medical technologies and the lives of vulnerable patients drives our commitment to this partnership."

The CRC-P grant program, known for fostering innovation and strong partnerships between industry and research organisations, is highly competitive and evaluated by an independent committee of industry experts. Navi's success in securing this grant recognizes not only its potential to transform pediatric care but also acknowledges the collaborative efforts of multiple stakeholders dedicated to advancing medical technologies.

Shing Yue Sheung, Navi's Chief Operating Officer, expressed gratitude for the support and belief in Navi's vision: “The CRC-P grant funding will play a critical role in advancing our device's path to market, and highlights the hard work and dedication of our entire team. We are immensely grateful to our Project Partners for their support and belief in our vision of helping children live brighter, healthier futures."

For more information, visit navitechnologies.com and design-industry.com.au

Image Above: Navi Medical Technologies CEO Alex Newton with an early-stage Neonav clinical prototype in a NICU setting.

Media Contact:

Shing Yue Sheung (COO & Co-Founder, Navi Medical Technologies)
Tel: +61 (3) 9059 4919
Email: info@navitechnologies.com

Rod Wiebenga (Head of D+I Melbourne)
Tel: +61 (3) 9032 2999
Email: rod.wiebenga@design-industry.com.au

About Navi Medical Technologies

Founded in 2017, the Navi Medical Technologies team is an award-winning mix of business experts, biomedical engineers, and a senior neonatologist who have devoted thousands of hours to a singular task: building and commercialising a medical device that enables doctors and nurses to deliver better care for newborn and pediatric patients. The team has spent countless days in neonatal and pediatric intensive care units, observing life-saving procedures firsthand, talking to clinical staff to gain a deeper understanding of the challenges they face on a daily basis, and developing innovative solutions to engineering problems. However, this endeavor is much more than a technical or business challenge—it has become a truly personal labor of passion. The Neonav® ECG Tip Location System is currently in development and is designed specifically for newborn and pediatric patients. Through Navi’s proprietary software and hardware solutions, the Neonav® system will provide clinicians with real-time tip location feedback during the insertion procedure and can be used for post-procedure surveillance of catheter migration.

In late 2022, Navi Medical Technologies announced that the US Food and Drug Administration (FDA) had granted Breakthrough Device Designation (BDD) for the Neonav® ECG Tip Location System as a method for navigating and positioning umbilical venous catheters in newborn patients. The Breakthrough Device Designation was supported by early stage Neonav® clinical studies conducted at the Royal Women’s Hospital in Melbourne, Australia, as well as other well documented published studies that highlight the adverse events associated with malpositioned umbilical venous catheters, and other central lines, used in the care of newborns.

About Design + Industry

Your End-to-End Partner in the Commercialisation of Medical Device Innovation: Elevate your medical technology solutions, our ISO 13485:2016 certified multidisciplinary team of experts offer a comprehensive end-to-end product development service, guiding your team from concept to commercialisation. We prioritise user-centric design, close collaboration, and seamless integration, ensuring the delivery of high-quality, market-ready products that build brands + make a positive impact on people's lives. Contact us online or visit one of our offices in Melbourne, Sydney, or Newcastle — Let's work together to bring your product to life, and elevate the quality of care for patients who need it most.

Phone: +61 2 9555 1166
Email: info@design-industry.com.au

Above: Navi Medical Technologies CEO Alex Newton with an earlier version of the Neonav clinical prototype in a NICU setting.